Overview
Boston Scientific's neuromodulation portfolio spans spinal cord stimulation, deep brain stimulation, and sacral neuromodulation for pain, movement disorders, and pelvic conditions. Their Vercise Genus DBS system and WaveWriter Alpha SCS platform represent the company's latest advances in closed-loop, personalized neural therapy.
More in Neuromodulation
Latest industry news
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Target Brain Health
2026-07-11 · Funding
BrainCo Pushes to Commercialize Brain-Tech as China's BCI Ambitions Come Into Focus
2026-07-10 · Industry
FDA Clears PoNS Device for Stroke Rehabilitation, Broadening Neurostimulation's Clinical Reach
2026-07-09 · Policy
Neurovalens Wins FDA Approval for PTSD Therapy Targeting US Veterans
2026-07-08 · Policy
Company details
Category
⚡ Neuromodulation
Location
Marlborough, MA, USA
Funding
NYSE: BSX
Listed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →